EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
AbbVie (NYSE:ABBV) Trading 6.3% Higher - Still a Buy? - Zolmax
Why I Can't Stop Buying This Unstoppable Dividend Juggernaut
AbbVie's $11 Billion Immunology Bet
FDA Complete Response Letter (CRL) Explained: What It Means For Biotech Stocks
64 Years Old With $1.1 Million in a Traditional IRA. Here's Where I'm Allocating Capital
BOTOX® Cosmetic (onabotulinumtoxinA) Introduces The Confidence Collective's Entrepreneur Class of 2026 | Morningstar
After Apogee, 3 More Biotech Buyout Targets Wall Street Can't Stop Watching - 24/7 Wall St.
AbbVie Inc. $ABBV Shares Acquired by Signal Advisors Wealth LLC
SVB Wealth LLC Sells 10,374 Shares of AbbVie Inc. $ABBV
Great Place To Work Reveals Southeast Asia's Best Workplaces™ in Healthcare & Biopharma
SVB Wealth LLC Reduces Position in AbbVie Inc. $ABBV - Daily Political
Long-term follow-up of the transplant-eligible cohort of the EMN12/HOVON-129 study for primary plasma cell leukemia patients
Apogee Therapeutics downgraded to Hold from Buy at TD Cowen
AbbVie Just Sparked a 46% Rally in Apogee. Here's Why This $10.9 Billion Deal Could Be a Win for AbbVie Investors.
Therapeutics Stocks Q1 Recap: Benchmarking Biogen (NASDAQ:BIIB)
AbbVie (NYSE:ABBV) Receives "Overweight" Rating from Piper Sandler - Markets Daily
AbbVie (NYSE:ABBV) Receives "Overweight" Rating from Piper Sandler - Zolmax
AbbVie (ABBV) Is Buying Apogee Therapeutics For $10.9 Billion To Rebuild Its Pipeline
AbbVie (ABBV) Gains EU Approval for Expanded Use of Hepatitis C Treatment Maviret
3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal
AbbVie (ABBV) Secures EU Approval for Skyrizi in Pediatric Psoriasis Treatment
Apogee Therapeutics (NASDAQ:APGE) Stock Rating Lowered by Citigroup - Zolmax
Apogee Therapeutics (NASDAQ:APGE) Stock Rating Lowered by Citigroup - Markets Daily
Apogee Therapeutics (NASDAQ:APGE) Downgraded to Hold Rating by Citigroup - Stock Observer
AbbVie Announces European Commission Approval of SKYRIZI® for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis | INN
Wells Fargo Maintains Overweight on AbbVie (ABBV), Sees Value in Apogee Acquisition
Why AbbVie Stock Jumped Today
Generate Investment Management Ltd Sells 5,261 Shares of AbbVie Inc. $ABBV - Daily Political
Apogee Therapeutics (APGE) Hits Fresh High on AbbVie $10.9B Merger
AbbVie: Apogee Acquisition Brings Significant Weight to Immunology Pipeline | Morningstar
AbbVie's Immunology Dominance Contributes to Its Wide Economic Moat | Morningstar
2026's Biggest Biotech Myth: $10.9B Sale of a Phase II Drug from a 261 - Employee Company
ABBV's Acquisition Impacts Evommune's Outlook
Healthcare Stocks Gain in Mixed U.S. Session - Healthcare Roundup | Morningstar
Abbvie Inc to Acquire Apogee Therapeutics Call Transcript
The $11 Billion Reason Abbvie Stock Is Up Today
AbbVie is buying a biotech company working on an experimental eczema drug for $10.9 billion | Morningstar
Stock market today: S&P 500, Nasdaq slide as Big Tech, SpaceX hammered
Abbvie acquiring Apogee for $10.9B, Coca-Cola vs. IRS in appeals court
AbbVie (ABBV) Acquires Apogee Therapeutics for $10.9 Billion
AbbVie (NYSE:ABBV) Stock Price Up 6.3% - Should You Buy? - Stock Observer
AbbVie Up Nearly 7%, on Pace for Largest Percent Increase Since November 2020 - Data Talk | Morningstar
Stock market today: Dow rises, S&P 500 and Nasdaq fall as SpaceX stock declines and US-Iran peace talks remain in focus
Dow Jones Top Company Headlines at 11 AM ET: Chevron Strikes Power Deal With Microsoft for West Texas AI Data Center | AbbVie ... | Morningstar
Apogee Therapeutics Stock Soars 47% After AbbVie Acquisition
Why AbbVie Is Spending $11 Billion to Buy Apogee Therapeutics
AbbVie on Pace for Largest Percent Increase Since October 2025 - Data Talk | Morningstar
AbbVie to acquire Apogee Therapeutics in $10.9B deal
AbbVie (ABBV) Acquires Apogee Therapeutics, Impact on Regeneron Analyzed
AbbVie To Acquire Immunology Drug Maker Apogee For $10.9 Bln Cash; Shares Climb
AbbVie to Acquire Apogee Therapeutics in $10.9 Billion Deal
AbbVie to buy immunology drugmaker Apogee for close to $11B
Market Highlights: Getty Images Soars 179% on OpenAI Partnership, AbbVie Plans $11B Acquisition
AbbVie (ABBV) to Acquire Apogee Therapeutics for $10.9 Billion
AbbVie (ABBV) Set to Acquire Apogee Therapeutics for $10.9 Billion
AbbVie to Buy Apogee Therapeutics for $10.9 Billion in Cash - Update | Morningstar
AbbVie (ABBV) Pursues Apogee Therapeutics for Strategic Acquisition
Stocks making the biggest moves premarket: APGE, SPCX, ACA
AbbVie To Buy Apogee Therapeutics For $135.11/Share In Cash
AbbVie strikes $10.9 billion deal for Apogee Therapeutics
AbbVie Inc. $ABBV Shares Purchased by Westmount Partners LLC - Zolmax
AbbVie Inc. $ABBV Shares Purchased by Westmount Partners LLC
Uhlmann Price Securities LLC Buys 7,523 Shares of AbbVie Inc. $ABBV - Markets Daily
AbbVie (ABBV) Stock Dips as $10.9B Apogee Therapeutics Acquisition Nears Completion
AbbVie's (ABBV) Allergan Aesthetics Wins FDA Approval for Skinvive by Juvederm
Park National Corp OH Acquires 5,910 Shares of AbbVie Inc. $ABBV
Diversified Trust Co Buys 8,430 Shares of AbbVie Inc. $ABBV
3 Excellent Dividend Stocks to Buy on the Dip
Autologous stem cell transplantation for AL amyloidosis: a multicenter summary of outcomes 2010-2020
The 2 Factors That Will Decide Whether XLV Finally Catches the S&P 500 in 2026 - 24/7 Wall St.
The 2 Factors That Will Decide Whether XLV Finally Catches the S&P 500 in 2026 - AOL
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Moderna (MRNA)
Analysts Conflicted on These Healthcare Names: AbbVie (ABBV) and Moderna (MRNA)
AbbVie's biggest deal since 2019 could land soon
Union Savings Bank Makes New Investment in AbbVie Inc. $ABBV - Markets Daily
Hsbc Holdings PLC Increases Stock Holdings in AbbVie Inc. $ABBV
Winthrop Partners WNY LLC Makes New $1.32 Million Investment in AbbVie Inc. $ABBV - Zolmax
Fund Advisors of America Inc FL Invests $897,000 in AbbVie Inc. $ABBV - Markets Daily
Meadowbrook Advisors Group LLC Takes Position in AbbVie Inc. $ABBV
4,724 Shares in AbbVie Inc. $ABBV Acquired by Union Savings Bank
AbbVie Inc. $ABBV Shares Purchased by Hsbc Holdings PLC
9,655 Shares in AbbVie Inc. $ABBV Purchased by SHP Wealth Management
AbbVie Inc. $ABBV Shares Acquired by Corient Private Wealth LLC
AbbVie Inc. (NYSE:ABBV) Receives Average Recommendation of "Moderate Buy" from Analysts
SHP Wealth Management Invests $2.21 Million in AbbVie Inc. $ABBV - Stock Observer
Pure Financial Advisors LLC Acquires 7,705 Shares of AbbVie Inc. $ABBV - Daily Political
AbbVie (ABBV) Stock After DCF Upside And Elevated P/E Multiple
12 High Quality Stocks to Buy for the Long Term
AbbVie would gain an experimental eczema drug by buying biotech: report | Morningstar
AbbVie (ABBV) Nears $11B Acquisition of Apogee Therapeutics (APGE)
MidFirst Bank Invests $9.24 Million in AbbVie Inc. $ABBV - Zolmax
AbbVie Inc. $ABBV Shares Sold by Sit Investment Associates Inc.
AbbVie News
USD/JPY Forecast: Analyzing the 161.60 Threshold Amid BoJ Policy Friction and Intervention Risks
Dow Advances on Value Rotation While Tech Sell-Off and Plunging Crude Drag S&P 500, Nasdaq Lower
Crude Oil Price Forecast 2026–2030: Macro Fundamentals, Geopolitics, and Trading Strategies
SpaceX Stock Forecast 2027, 2031 and 2036: What the Lockup Schedule Means for SPCX Shares
Japan and South Korea Stocks Rebound as Nikkei Hits Fresh High and KOSPI Rises Over 1.5%
5 Ways South African Traders Can Capitalise on the SpaceX Listing Aftermath
Latest news
Show more
Kospi's $474 Billion Rout Exposes AI Concentration Risks Ahead of Micron Report
Gold Approaches Critical $4,000 Threshold as Hawkish Fed Repricing Eclipses Geopolitical Premium
WTI Crude Edges Higher but Remains Under Pressure Near $72.50 After Recent Low
Nasdaq Drops 2.21%, Micron Plunges 13% as Semiconductor Stocks Tumble
South Korean Chip Stocks Slide as Profit-Taking Hits Samsung and SK Hynix
